comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Clinical trials arena - Page 1 : comparemela.com
ASCO 24: Data shows survival benefit with J&J's subcutaneous Rybrevant
J&J's Rybrevant is expected to generate $4bn in sales by 2030, as per GlobalData estimates.
United-states
American
Astrazeneca-tagrisso
European-medicines-agency
American-society-of-clinical-oncology
American-society
Clinical-oncology
Annual-meeting
Johnson-innovative-medicine
Biologics-license-application
Clinical-trials-arena
Apellis and Sobi report data from Phase II C3 glomerulopathy trial
Pegcetacoplan treatment resulted in sustained improvements in proteinuria and kidney function stabilisation.
Caroline-baumal
Apellis-pharmaceuticals
Clinical-trials-arena
Novartis' atrasentan shows to reduce proteinuria in Phase III IgAN trial
Atrasentan’s safety profile in the trial was deemed favourable, aligning with previous data.
David-soergel
Metabolism-development-unit
Drug-administration
Novartis
Clinical-trials-arena
Imvax concludes enrolment in Phase IIb glioblastoma treatment trial
The company secured $35m in financing to support IGV-001’s clinical development.
John-furey
Drug-administration
Clinical-trials-arena
Eli Lilly's mirikizumab shows promise in Phase III Crohn's disease trial
Mirikizumab demonstrated significant improvements in Crohn's disease patients.
Eli-lilly
Mark-genovese
Drug-administration
European-medicines-agency
Lilly-immunology
Clinical-trials-arena
vimarsana © 2020. All Rights Reserved.